Status:
COMPLETED
Strategies to Improve Appropriate Referral to Rheumatologists
Lead Sponsor:
Maasstad Hospital
Conditions:
Rheumatic Disease
Arthralgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this cluster randomized controlled trial is to improve the number of effectively referred patients with IRD to the rheumatology outpatient clinic with either use of validated referral pro f...
Detailed Description
Rationale: Currently, only 22% of all patients referred to the rheumatologist by primary care are diagnosed with an inflammatory rheumatic disease (IRD). Previous research has shown that structured re...
Eligibility Criteria
Inclusion
- A primary care patient who is referred by the GP to the rheumatology outpatient clinic
- Subject must be able to understand and communicate with the rheumatologist
- Participant must give a written signed and dated informed consent before enrolment.
Exclusion
- Limited understanding of the Dutch language.
- Legally incapable or vulnerable subject as described in the Medical Research with Human Subjects Act (WMO).
Key Trial Info
Start Date :
February 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
544 Patients enrolled
Trial Details
Trial ID
NCT03454438
Start Date
February 28 2017
End Date
August 31 2021
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maasstad Hospital
Rotterdam, South Holland, Netherlands, 3079